WW Q1 revenue $168M, net loss $52M; clinical subs up 46%; reaffirms FY guidance; plans debt prepayment

WW INTERNATIONAL, INC.

2026-Q1 EPS reported -$5.20 revenue$168,261,000

Q1 revenue $168M, net loss $52M; adjusted EBITDA loss $1.8M vs prior adj EBITDA $26.9M (not comparable due to fresh start accounting).
End-of-period clinical subscribers 197K (+46% YoY); clinical subscription revenue $39M (+32% YoY).
Core+ subscribers 537K (+6% YoY); ARPU up 13% YoY due to mix shift to higher-value tiers.
Reaffirms FY2026 guidance: revenue $620-635M, Adj EBITDA $105-115M.
Expects to pay $37M cash in Q2 to reduce term loan principal by $42M; voluntary solicitation fully subscribed at 68.5% of par.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

WW INTERNATIONAL, INC. reported first quarter of fiscal 2026 ended March 31, 2026 results: revenue $168 million, net income $52.0 million. Guidance reaffirmed.

Period: first quarter of fiscal 2026 ended March 31, 2026
Revenue: $168 million
Net income: $52.0 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Announces First Quarter 2026 Results Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32% year-over-year Reaffirms Full Year 2026 Financial Guidance Announces Fully Subscribed Debt Prepayment Solicitation as Part

View on SEC.gov

Browse all earnings releases →

WW INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-210279

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.